Page last updated: 2024-11-05

tolperisone and Arteriosclerosis Obliterans

tolperisone has been researched along with Arteriosclerosis Obliterans in 3 studies

Tolperisone: A centrally acting muscle relaxant that has been used for the symptomatic treatment of spasticity and muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1211)

Arteriosclerosis Obliterans: Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SOOS, S1
LINKE, H1
Briskin, BS1
Dibirov, MD1
Evseev, IuN1
Novosel'tsev, OS1

Other Studies

3 other studies available for tolperisone and Arteriosclerosis Obliterans

ArticleYear
[PERIPHERAL VASODILATOR ACTION OF MYDETON].
    Orvosi hetilap, 1964, Jul-19, Volume: 105

    Topics: Arteriosclerosis Obliterans; Cardiovascular Agents; Drug Therapy; Humans; Raynaud Disease; Tolperiso

1964
[EXPERIENCE WITH A MYOTONOLYTIC (MYDOCALM) IN THE TREATMENT OF ARTERIAL OCCLUSIVE DISEASE OF THE EXTREMITIES].
    Wiener medizinische Wochenschrift (1946), 1964, May-02, Volume: 114

    Topics: Arteriosclerosis Obliterans; Drug Therapy; Electromyography; Extremities; Hemiplegia; Humans; Interm

1964
[Treatment of chronic arterial insufficiency of legs with midocalm in elderly].
    Khirurgiia, 2000, Issue:4

    Topics: Administration, Oral; Aged; Arteriosclerosis Obliterans; Humans; Injections, Intramuscular; Ischemia

2000